Two of the four members of the Pro Football Hall of Fame class announced Thursday claim the city loudly — tight end Antonio ...

San Diego State will begin a two-game road trip this weekend, starting with a trip to Colorado State on Saturday night. The Aztecs (15-5, 8-3), ranked No. 50 in ...

SAN DIEGO, CA – OCTOBER 15: Antonio Gates #85 of the San Diego Chargers celebrates his first quarter touchdown against the Denver Broncos as teammate Malcom Floyd #80 looks on during the NFL game at ...

The Chargers can build off their surprise 2024 playoff run with a strong 2025 offseason. But that could mean losing a beloved ...

Colonel (Retired) Brian S. Campbell age 65, passed on to his heavenly host December 13th, 2024, after his years spent fighting the good fight. He was born on 14 March 1959 to Paul and Beverly ...

The Los Angeles Chargers had some major names at the 2025 NFL Pro Bowl over the weekend. While the AFC conference lost the game itself, individual players like Derwin James Jr. had big performances.

It seems like Tennessee head coach Brian Callahan has some high expectations for Shedeur Sanders. Sanders met with multiple members of the Titans staff last week, including Callahan and newly ...

Low clouds and fog. Low 52F. Winds light and variable. 52°F Low clouds and fog. Low 52F. Winds light and variable. Foggy. Low 49F. Winds light and variable. 49°F Foggy. Low 49F. Winds light and ...

While the 2024 season overall was a success and very good turnaround for the Los Angeles Chargers, it ended in a rather disappointing fashion, losing 32-12 to the Houston Texans in the Wild Card ...

Detroit Lions’ nickel defender Brian Branch was taking in his first ... Four-time Pro Bowl safety Derwin James of the Los Angeles Chargers was hamming it up with the rest of the all-stars ...

As a result, Roche moved its research facilities to Nutley, while the US Headquarters in Nutley was moved to Genentech’s facility in San Francisco. Genentech strengthens Roche’s access to ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).